Compare GALT & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GALT | MFIN |
|---|---|---|
| Founded | 2000 | 1995 |
| Country | United States | United States |
| Employees | N/A | 179 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 276.7M |
| IPO Year | 2008 | N/A |
| Metric | GALT | MFIN |
|---|---|---|
| Price | $4.01 | $11.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 301.3K | 51.9K |
| Earning Date | 05-15-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 5.18% |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.02 |
| P/E Ratio | ★ N/A | $6.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $7.85 |
| 52 Week High | $7.13 | $12.26 |
| Indicator | GALT | MFIN |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 61.12 |
| Support Level | $2.74 | $9.50 |
| Resistance Level | $4.35 | $12.26 |
| Average True Range (ATR) | 0.29 | 0.26 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 35.08 | 75.72 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The four operating segments are, (1) recreation, (2) home improvement, (3) commercial and (4) taxi medallion The company generates maximum revenue from the Recreation segment. The company's geographic Concentrations are in united states diversified in California, Wisconsin, New York, Texas and others.